Previously submitted to: JMIR Research Protocols (no longer under consideration since Aug 11, 2021)
Date Submitted: Feb 19, 2018
Open Peer Review Period: Mar 2, 2018 - Mar 19, 2018
(closed for review but you can still tweet)
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
A New Fracture Liaison Service Design Using a Mobile Application and Medical Artificial Intelligence : test
Background:
While the clinical design of a Fracture Liaison Service(FLS) has been used as a localized healthcare service in a previous study, thus far there has not been an international mobile application, such as a FLS using smart phones. test
Objective:
The goal of our study is to improve the prevention of secondary fractures using a Mobile FLS Application.
Methods:
We have developed a Fracture Liaison Service as an Android-OS application and released this service as a secondary fracture prevention program for osteoporotic fracture patients.
Results:
We have released the final version of the FLS mobile application in Google’s PlayStore. The new model of the FLS mobile application can be practically commercialized, and the effective second-order fracture prevention system is based on an open policy platform.
Conclusions:
We hope to contribute to the prevention and management of osteoporotic fractures and osteoporosis worldwide via this FLS mobile application. In the future, an intelligent personal FLS is definitely possible, by applying a Medical AI based on a huge DB.
Clinicaltrial:
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.